Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $46.3300 (0.41%) ($46.3300 - $46.3300) on Fri. Apr. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.83% (three month average) | RSI | 79 | Latest Price | $46.3300(0.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.5% a day on average for past five trading days. | Weekly Trend | HALO advances 4.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(49%) IWO(49%) IWM(47%) IWC(43%) IWN(43%) | Factors Impacting HALO price | HALO will decline at least -1.415% in a week (0% probabilities). VIXM(-31%) VXX(-12%) UUP(-11%) IGOV(-3%) GLD(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.415% (StdDev 2.83%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $44.99(2.98%) | 10 Day Moving Average | $43.85(5.66%) | 20 Day Moving Average | $43(7.74%) | To recent high | -10.8% | To recent low | 17.1% | Market Cap | $6.332b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |